Aristopharma Ltd. is one of the top 10 pharmaceutical companies in Bangladesh. The company started its journey in 1986 with the honest promise to provide quality medicines at affordable prices to the countrymen. Aristopharma now owns two plants- one at Shampur, Dhaka & another at Gachha, Gazipur. The Shampur plant is located at Shampur-Kadamtali I/A, 10 km South-East of central Dhaka. Although it is the 1st plant of Aristopharma, with continuous expansion & upgradation, it is now equipped with highly sophisticated and advanced facilities. The facility is planned and designed to meet local as well as international demand both qualitatively and quantitatively. Aristopharma manufactures medicines of a wide range of therapeutic classes like antiulcerants, antibiotics, NSAIDs, antipyretics, vitamins & minerals, laxatives, cardiovasculars, antidiabetics, steroids, antispasmodics, antihistamines, antipsychotics, antiemetics, antiseptics etc. in different dosage forms starting from a simple tablet, capsule, syrup, suspension, cream, ointment, gel to sophisticated injection, lyophilized injection, prefilled syringe, HFA inhaler, suppository, insulin & other biotech products. The WHO-approved cGMP guidelines are strictly followed in every single operation of the plant.
The Gachha plant is around 30 km North-West of central Dhaka. The plant is spread over more than 13 acres of land and contains dedicated & separate buildings for Cephalosporins, Ophthalmic & Herbal products. Another new facility for General Solid Products is also underway in this plant. All these facilities have been developed as per the guidelines of regulated markets like UKMHRA, USFDA, etc.
It started manufacturing sterile ophthalmic products in 2002 and presently maintains the no. 1 position in the ophthalmic market in Bangladesh. In Aristopharma, quality is a journey, not a goal. It continuously sets higher standards and feels passionate to achieve that. The motto of Aristopharma’s quality policy is “Quality – the unit we count” and by quality, we don’t mean only product quality rather it is infused in every activity that we do.
Aristopharma conducted bioequivalence study for its products like Omep (Omeprazole) Capsule, Metacard MR (Trimetazidine) Tablet, Lodipin-5 (Amlodipine) Tablet, AZ (Azithromycin) Capsule & Suspension, Aropen (Meropenem) Injection etc. The company also conducted clinical trials on Taxetil (Cefpodoxime), Afix (Cefixime), Metacard MR (Trimetazidine), Ipec-Plus (Iron Polymaltose+Zinc+Folic Acid), etc. and the results of these studies showed that they are as effective as innovators’ brands. It may be mentioned that clinical trials on some other products are ongoing at different hospitals and universities.
With the aim to cope with the challenges of globalization, Aristopharma Ltd. stepped beyond the boundary of Bangladesh in 2000, Vietnam being the first country to export. Today Aristopharma exports its quality medicines to 31 countries of 5 continents and is moving aggressively to expand and extend its export market. As a recognition of its Quality Management System, Aristopharma achieved ISO 9001:2000 certificate in 2005. The certificate was issued by Orion Registrar Inc. USA, one of the prime certification bodies in the world. Later on, the certificate was upgraded to ISO 9001:2008 standard. Today around 7000 employees are relentlessly working for Aristopharma in its journey to build a healthier future.
FR
DE